3 Ultra-Risky Biotech Stocks That Could Make You Filthy Rich [The Motley Fool]
BioXcel Therapeutics, Inc. (BTAI)
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am
Check Earnings Report
Company Research
Source: The Motley Fool
The biotechnology industry's chock-full of stocks that could quickly skyrocket overnight and make you filthy rich in the process. All three of these clinical-stage biotechs are relatively small at the moment, but they have potential blockbuster drugs in development that could send their stock prices screaming higher.Company (Symbol)Market CapLead CandidateIndicationBicycle TherapeuticsNASDAQ:BCYC$269.9 millionBT78OncologyBioXcel TherapeuticsNASDAQ:BTAI$57 millionBXCL50NeuroscienceIGM BiosciencesNASDAQ:IGMS$.8 billionIGM-2323Data source: Yahoo! Finance.Image source: Getty Images.. Bicycle Therapeutics: Bicyclic peptidesThis biotech is pioneering the development of short amino acid sequences that form highly stable loops called bicyclic peptides, or bicycles. Earlier this year,RocheOTC:RHHBYBefore Bicycle's relationship with Roche passes milestones with significant payouts, we'll probably have mid-stage clinical trial results from the company's lead candidate, BT78. This is a bicycle th
Show less
Read more
Impact Snapshot
Event Time:
BTAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BTAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BTAI alerts
High impacting BioXcel Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
BTAI
News
- Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their RightsBusiness Wire
- BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting [Yahoo! Finance]Yahoo! Finance
- BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home SettingGlobeNewswire
- BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI® [Yahoo! Finance]Yahoo! Finance
- BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®GlobeNewswire
BTAI
Earnings
- 11/12/25 - Miss
BTAI
Sec Filings
- 1/12/26 - Form 4
- 1/12/26 - Form 4
- 1/12/26 - Form 4
- BTAI's page on the SEC website